Image of an AI robot examining samples under a microscope in the lab
Source: Adobe Stock
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

Medical tech company LBT Innovations Ltd (ASX:LBT) has seen its share price rise more than 33% on news of a deal worth up to $4.1 million which it has inked with multinational Astrazeneca for the supply and maintenance of its platform technology, namely the APAS® Independence instruments.

This product – also known as the Automated Plate Assessment System (APAS) – integrates artificial intelligence and machine learning software to automate the imaging, analysis and interpretation of microbiology culture plates.

According to the agreement signed between the two companies, LBT will sell five APAS® Independence instruments to AstraZeneca AB, as well as providing annual
maintenance and support services over seven years, with the contract valued between USD 2.2 million to 2.7 million, or AU$3.4 million to AU$4.1 million.

LBT CEO & Managing Director Brent Barnes said that securing such a deal indicated the value of the APAS technology, with five instruments to be rolled out across a number of AstraZeneca’s manufacturing operations.

“This decision was made based on demonstrated performance of the technology within the AstraZeneca manufacturing processes and provides credibility for the technology more broadly,” he said.

“This milestone provides evidence and confidence that the APAS® Independence is a fully validated technology that meets the stringent requirements for environmental monitoring during drug manufacturing, applicable to all customers globally for this application.

“Pleasingly, evaluations with additional multinational pharmaceutical customers are expected to commence in the current quarter.”

At 11:46 AEST, LBT shares were trading at 2 cents, a rise of 33.33% since the market opened.

LBT by the numbers
More From The Market Online
Disability NDIS concept

Freedom Care Group reveals NDIS wants to ban it providing program services

Shares in Freedom Care Group (ASX:FCG) were down more than -3% on Wednesday after revealing the…
Small pile of rare earth minerals

Critica confirms high grade REE mineralisation at Jupiter with 3,074 ppm intercept

Critica Ltd has confirmed high grade REE mineralisation at the Jupiter target, part of the larger…
AI gen vanadium flow battery concept

Aussie Vanadium unveils vision for a 100MW modular vanadium flow battery

Australian Vanadium has kicked off Project Lumina, seeking to build a modular 100MW Vanadium Flow Battery…
Crosse section of the earth

Earths Energy confirms Paralana as an Enhanced Geothermal Systems Program project

Earths Energy Ltd has completed preliminary work on its Techno Economic Feasibility study for the Paralana…